Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma.
about
Hepatitis B Virus X Protein and HepatocarcinogenesisMolecular mechanism of hepatitis B virus-induced hepatocarcinogenesisHBV induced HCC: major risk factors from genetic to molecular levelTreating cancer as an infectious disease--viral antigens as novel targets for treatment and potential prevention of tumors of viral etiologyTransformation of human liver L-O2 cells mediated by stable HBx transfection.Hepatocarcinogenesis associated with hepatitis B, delta and C viruses.The X-linked tumor suppressor TSPX interacts and promotes degradation of the hepatitis B viral protein HBx via the proteasome pathway.Recent developments in the first detection of hepatocellular carcinomaGenotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus.Structural and biochemical analysis of Bcl-2 interaction with the hepatitis B virus protein HBxAnti-hepatitis B virus X protein in sera is one of the markers of development of liver cirrhosis and liver cancer mediated by HBV.HBx protein promotes oval cell proliferation by up-regulation of cyclin D1 via activation of the MEK/ERK and PI3K/Akt pathways.Hepatitis B virus X gene and hepatocarcinogenesis.Effects of hepatitis B virus mutations on its replication and liver disease severity.The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53.Effect of Hepatitis B Virus X Gene on the Expression Level of p53 Gene using Hep G2 Cell Line.Involvement of hepatitis B virus X gene (HBx) integration in hepatocarcinogenesis via a recombination of HBx/Alu core sequence/subtelomeric DNA.Identification of a natural mutant of HBV X protein truncated 27 amino acids at the COOH terminal and its effect on liver cell proliferation.Interference of Apoptosis by Hepatitis B Virus.Modeling human liver cancer heterogeneity: virally induced transgenic models and mouse genetic models of chronic liver inflammation.HBx activates FasL and mediates HepG2 cell apoptosis through MLK3-MKK7-JNKs signal module.Detection of antibodies against epidermodysplasia verruciformis-associated canine papillomavirus 3 in sera of dogs from Europe and Africa by enzyme-linked immunosorbent assay.Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.A rational design for hepatitis B virus X protein refolding and bioprocess development guided by second virial coefficient studies.Prognostic analysis in chronic hepatitis B patients: a retrospective study of 216 cases about Scheuer scores, in situ expression of viral antigens and tissue hepatitis B virus DNA levels.MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
P2860
Q26744503-610A65A7-C6C4-47E4-ACFC-3DA6AA0C06FBQ26823512-56398111-9F5C-4FE4-AC90-FE92B98D712DQ26825274-3E934991-91CE-46EF-9760-B03032449B22Q33304454-57FC9AD8-D24B-4D66-8914-5AD3C5241245Q33552832-195AFB05-3C40-400F-8961-EFCB6DF0B104Q33899640-ACB0786E-EE87-4E2D-912C-14424A1E3DE9Q33988130-CAC8C277-7EA5-445A-B047-EBCB6FC7A5A1Q34055894-65FD52C7-694B-4F78-BD26-0736B13A939AQ36498203-B7A0E1B4-55D9-4FFF-8F05-F2699FED3537Q36646443-25B95066-1F5D-4EA4-A62C-5BA2665EAC75Q37335272-949DE833-BCF7-4DAF-9B6E-7E6AA970E06DQ37683967-5AD32A9A-3C0E-43D9-85C7-2BB3D3F29FF0Q37885837-74E4FBBD-8D74-4677-B048-747B33FAD0EBQ38080743-B1B131BB-D458-430D-A76F-BE1BE6752267Q38246712-DD68459E-CA77-45AD-A16C-DA236E364F72Q38922362-AA0FE365-2FC7-45A1-9BC5-CC579AE8FA1CQ39024284-ED18C203-E5C2-4485-B580-64D7A7281A7DQ39318333-B7E2D6C8-EBFC-457A-B41B-8222F2868C17Q39999789-845F27A9-51F6-4EC1-A357-312E389F76ADQ40078335-349ED7F1-7307-44DB-B958-3C9EE2DF6462Q41636479-5FD9ACD8-A104-4EE1-93B3-0E57E8D3F601Q42556555-9973A9F6-154E-4429-B67C-8F2A5815CC4FQ43204000-63B824FD-7684-49EF-B9E9-2E1C2519DCFDQ43952154-6271654F-BDCC-4769-BD73-61C675B65B83Q45370002-EA6F0D0A-8B9F-4B37-A0B4-AC49A07319BBQ45420734-FF2EA82E-FBCA-433B-8EF9-D8D2AFCB5D12Q47155849-3B537794-8DE6-4C8E-9BB2-C8D757DCC18A
P2860
Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Detection of the hepatitis B v ...... uman hepatocellular carcinoma.
@ast
Detection of the hepatitis B v ...... uman hepatocellular carcinoma.
@en
Detection of the hepatitis B virus X protein
@nl
type
label
Detection of the hepatitis B v ...... uman hepatocellular carcinoma.
@ast
Detection of the hepatitis B v ...... uman hepatocellular carcinoma.
@en
Detection of the hepatitis B virus X protein
@nl
prefLabel
Detection of the hepatitis B v ...... uman hepatocellular carcinoma.
@ast
Detection of the hepatitis B v ...... uman hepatocellular carcinoma.
@en
Detection of the hepatitis B virus X protein
@nl
P2093
P2860
P1476
Detection of the hepatitis B v ...... uman hepatocellular carcinoma.
@en
P2093
Cheng-Chung Wu
Ching-Ting Hsu
Chuang-Yu Lin
Guang-Yuh Hwang
Jing-Chyi Wang
Li-Mei Huang
Sheng-Shun Yang
Yan-Hsiung Wang
P2860
P304
P356
10.1128/JCM.41.12.5598-5603.2003
P407
P577
2003-12-01T00:00:00Z